Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.13)
# 3,821
Out of 5,131 analysts
345
Total ratings
27.63%
Success rate
-11.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTYX Ventyx Biosciences | Downgrades: Neutral | $14 | $13.81 | +1.38% | 17 | Jan 8, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $48 → $62 | $28.41 | +118.23% | 4 | Dec 24, 2025 | |
| VTVT vTv Therapeutics | Maintains: Buy | $36 → $47 | $35.58 | +32.12% | 3 | Dec 19, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $28 → $32 | $21.01 | +52.31% | 7 | Dec 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $36 → $45 | $28.08 | +60.26% | 23 | Dec 11, 2025 | |
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $1.75 | +985.71% | 13 | Nov 25, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $52 → $51 | $44.67 | +14.17% | 13 | Nov 24, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $12 → $15 | $4.86 | +208.96% | 2 | Nov 12, 2025 | |
| SANA Sana Biotechnology | Maintains: Buy | $11 → $9 | $4.56 | +97.37% | 12 | Nov 7, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $5 | $1.61 | +210.56% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $42 | $14.35 | +192.68% | 19 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $72 | $33.62 | +114.16% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.11 | +981.08% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $28.47 | +110.75% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.56 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.91 | +488.24% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $7.25 | +451.72% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $12.40 | +182.26% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.59 | +1,246.12% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.68 | +144.57% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.51 | +1,224.50% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $13.37 | +169.26% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $66.27 | +73.53% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $8.01 | +3,395.63% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.15 | +272.09% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.80 | +971.43% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.09 | +761.24% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.69 | +4,848.78% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.65 | +985.10% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.34 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.76 | +2,254.17% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.69 | +4,674.31% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.49 | - | 1 | Apr 25, 2024 |
Ventyx Biosciences
Jan 8, 2026
Downgrades: Neutral
Price Target: $14
Current: $13.81
Upside: +1.38%
Agios Pharmaceuticals
Dec 24, 2025
Maintains: Buy
Price Target: $48 → $62
Current: $28.41
Upside: +118.23%
vTv Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $36 → $47
Current: $35.58
Upside: +32.12%
Arcus Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $28 → $32
Current: $21.01
Upside: +52.31%
Olema Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $36 → $45
Current: $28.08
Upside: +60.26%
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $1.75
Upside: +985.71%
AnaptysBio
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $44.67
Upside: +14.17%
Artiva Biotherapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $4.86
Upside: +208.96%
Sana Biotechnology
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.56
Upside: +97.37%
Context Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $1.61
Upside: +210.56%
Oct 30, 2025
Maintains: Buy
Price Target: $38 → $42
Current: $14.35
Upside: +192.68%
Oct 27, 2025
Maintains: Buy
Price Target: $27 → $72
Current: $33.62
Upside: +114.16%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $1.11
Upside: +981.08%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $28.47
Upside: +110.75%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.91
Upside: +488.24%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $7.25
Upside: +451.72%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $12.40
Upside: +182.26%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.59
Upside: +1,246.12%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.68
Upside: +144.57%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.51
Upside: +1,224.50%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $13.37
Upside: +169.26%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $66.27
Upside: +73.53%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $8.01
Upside: +3,395.63%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.80
Upside: +971.43%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.09
Upside: +761.24%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.69
Upside: +4,848.78%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.65
Upside: +985.10%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.34
Upside: -
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.76
Upside: +2,254.17%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.69
Upside: +4,674.31%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.49
Upside: -